Abstract:It is urgent to identify novel early diagnostic markers and therapeutic targets for non-small-cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases and has a 5-year survival rate of 4–17%. Here, chromatin immunoprecipitation (ChIP) was used to identify DNA‒protein interactions, RNA methylation was determined by methylated RNA immunoprecipitation (MeRIP), RNA stability was tested by an RNA decay assay. We showed that RAD21, a member of the cohesin complex, is upregulated in NSCLC tissues and cell lines and found to be an independent prognostic factor for overall survival (OS) of NSCLC patients. Mechanistically, the cohesin loading factor Nipped-B-Like Protein (NIPBL) promoted RAD21 gene transcription by enhancing histone H3 lysine 27 (H3K27) demethylation via recruiting lysine demethylase 6B (KDM6B) to the RAD21 gene promoter. RAD21 enhanced phosphatidylinositol 3-kinase (PI3K) gene transcription, and NIPBL reversed the effect of enhancer of zeste 2; catalytic subunit of polycomb repressive complex 2 (EZH2) on RAD21-mediated PI3K gene transcription by disrupting the association between EZH2 and RAD21. Moreover, NIPBL level was increased by stabilization of its transcripts through mRNA methylation. These findings highlight the oncogenic role of RAD21 in NSCLC and suggest its use as a potential diagnostic marker and therapeutic target for NSCLC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify new early - diagnosis markers and treatment targets in non - small - cell lung cancer (NSCLC). Specifically, the research focuses on the role of RAD21 in NSCLC and the specific mechanism by which it promotes tumorigenesis through the PI3K signaling pathway. RAD21 is a component of the cohesin complex and is known to play a role in the occurrence and development of various cancers. However, the exact role of RAD21 in NSCLC is not fully understood. In addition, the role of NIPBL, as a loading factor for RAD21, in NSCLC has not been fully elucidated either. Therefore, the main purpose of this study is to further explore whether RAD21 exerts its effects through the PI3K signaling pathway and to reveal the relationship between RAD21 and NIPBL in NSCLC. ### Research Background - **Non - small - cell lung cancer (NSCLC)**: It accounts for 85% of all lung cancer cases, and the 5 - year survival rate is only 4% - 17%. - **RAD21**: A component of the cohesin complex, involved in sister chromatid separation. Previous studies have shown that RAD21 is highly expressed in various cancers and is associated with poor prognosis. - **NIPBL**: A cohesin - loading factor, involved in chromosome condensation, genomic stability, and DNA repair. High expression of NIPBL in NSCLC is related to poor prognosis of patients. - **PI3K signaling pathway**: It plays a key regulatory role in various cancers, and inhibiting this pathway can inhibit tumor progression. ### Research Objectives - **To determine the expression level of RAD21 in NSCLC and its relationship with patient prognosis**. - **To explore the mechanism by which RAD21 promotes the occurrence of NSCLC through the PI3K signaling pathway**. - **To reveal the role of NIPBL in regulating the expression and function of RAD21**. ### Main Findings - **RAD21 is highly expressed in NSCLC tissues and cell lines** and is an independent prognostic factor. - **NIPBL promotes RAD21 gene transcription by enhancing H3K27 demethylation**. - **RAD21 enhances PI3K gene transcription by directly binding to the PI3K gene promoter**. - **NIPBL reverses the effect of EZH2 on RAD21 - mediated PI3K gene transcription by disrupting the binding between EZH2 and RAD21**. - **High expression of RAD21 promotes the proliferation, migration, and invasion of NSCLC cells** and inhibits apoptosis. ### Conclusion This study reveals the oncogenic role of RAD21 in NSCLC and proposes the possibility of RAD21 as a potential diagnostic marker and treatment target. At the same time, the study also clarifies the important role of NIPBL in regulating the expression and function of RAD21, providing a theoretical basis for further exploration of treatment strategies for NSCLC.

NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer

LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation.

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation

LncRNA RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer via upregulation of RAD51B

High Expression of Rad51c Predicts Poor Prognostic Outcome and Induces Cell Resistance to Cisplatin and Radiation in Non-Small Cell Lung Cancer

Identification of NLE1/CDK1 Axis As Key Regulator in the Development and Progression of Non-Small Cell Lung Cancer

PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway

Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer

Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer

NudCD1 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells through the Activation of IGF1R-ERK1/2

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-β signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1

Nicotinamide Adenine Dinucleotide Kinase Promotes Lymph Node Metastasis of NSCLC Via Activating ID1 Expression Through BMP Pathway

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Loss of BLK Expression As a Potential Predictor of Poor Prognosis and Immune Checkpoint Blockade Response in NSCLC and Contribute to Tumor Progression

Highly Frequent Promoter Methylation and PIK3CA Amplification in Non-Small Cell Lung Cancer (NSCLC).

Upregulation of Long Intergenic Noncoding RNA 00673 Promotes Tumor Proliferation Via LSD1 Interaction and Repression of NCALD in Non-Small-cell Lung Cancer.

Cohesin mutation sensitizes cancer cells to anti-PD-1 therapy through endogenous retrovirus-mediated PD-L1 upregulation

RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer through upregulation of RAD51B

A Novel LncRNA Transcript, RBAT1, Accelerates Tumorigenesis Through Interacting with HNRNPL and Cis-Activating E2F3